Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
PLoS One. 2013 Jul 25;8(7):e67498. doi: 10.1371/journal.pone.0067498. Print 2013.
Beta cells of pancreatic islets are susceptible to functional deficits and damage by hypoxia. Here we aimed to characterize such effects and to test for and pharmacological means to alleviate a negative impact of hypoxia.
Rat and human pancreatic islets were subjected to 5.5 h of hypoxia after which functional and viability parameters were measured subsequent to the hypoxic period and/or following a 22 h re-oxygenation period. Preconditioning with diazoxide or other agents was usually done during a 22 h period prior to hypoxia.
Insulin contents decreased by 23% after 5.5 h of hypoxia and by 61% after a re-oxygenation period. Preconditioning with diazoxide time-dependently alleviated these hypoxia effects in rat and human islets. Hypoxia reduced proinsulin biosynthesis ((3)H-leucine incorporation into proinsulin) by 35%. Preconditioning counteracted this decrease by 91%. Preconditioning reduced hypoxia-induced necrosis by 40%, attenuated lowering of proteins of mitochondrial complexes I-IV and enhanced stimulation of HIF-1-alpha and phosphorylated AMPK proteins. Preconditioning by diazoxide was abolished by co-exposure to tolbutamide or elevated potassium (i.e. conditions which increase Ca(2+) inflow). Preconditioning with nifedipine, a calcium channel blocker, partly reproduced effects of diazoxide. Both diazoxide and nifedipine moderately reduced basal glucose oxidation whereas glucose-induced oxygen consumption (tested with diazoxide) was unaffected. Preconditioning with diaxoxide enhanced insulin contents in transplants of rat islets to non-diabetic rats and lowered hyperglycemia vs. non-preconditioned islets in streptozotocin-diabetic rats. Preconditioning of human islet transplants lowered hyperglycemia in streptozotocin-diabetic nude mice.
胰岛β细胞容易受到缺氧导致的功能缺陷和损伤。本研究旨在研究这些影响,并寻找减轻缺氧负面影响的药物治疗方法。
将大鼠和人胰岛在缺氧 5.5 小时后,测量缺氧后的功能和存活参数,以及在随后的 22 小时复氧期后测量这些参数。在缺氧前的 22 小时通常进行二氮嗪或其他药物的预处理。
缺氧 5.5 小时后胰岛素含量下降 23%,复氧后下降 61%。二氮嗪在大鼠和人胰岛中的预处理时间依赖性地减轻了这些缺氧作用。缺氧使前胰岛素生物合成减少(3H-亮氨酸掺入前胰岛素)35%。预处理减少了 91%的减少。预处理减少了缺氧引起的坏死 40%,减弱了线粒体复合物 I-IV 蛋白的降低,并增强了 HIF-1-α和磷酸化 AMPK 蛋白的刺激。二氮嗪预处理被甲苯磺丁脲或高钾(即增加 Ca2+流入的条件)共暴露所消除。硝苯地平,一种钙通道阻滞剂,部分再现了二氮嗪的作用。二氮嗪和硝苯地平均适度降低基础葡萄糖氧化,而葡萄糖诱导的耗氧量(用二氮嗪检测)不受影响。二氮嗪预处理增强了大鼠胰岛移植到非糖尿病大鼠中的胰岛素含量,并降低了链脲佐菌素糖尿病大鼠中与未预处理胰岛相比的高血糖。预处理的人胰岛移植降低了链脲佐菌素糖尿病裸鼠的高血糖。
1)预先阻断 Ca2+流入与较低的缺氧诱导损伤相关,2)预处理影响基础线粒体代谢并加速缺氧反应性和潜在保护性因子的激活,3)结果表明,K+-ATP 通道开放剂的预处理具有胰岛移植的治疗潜力。